
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.
This video was recorded at the National Community Pharmacists Association's (NCPA) 2015 Annual Convention.






